Strategic Mill Is Set To Be Near-term Revenue Driver for

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
219
Strategic Mill Is Set To Be Near-term Revenue Driver for LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) in Canada’s Leading Gold Producing Greenstone Belt

- LaFleur Minerals is a Canadian gold explorer and near-term producer with a fully owned mill onsite at its Quebec Abitibi Belt Project
- The company recognizes that the uniquely located Beacon Gold Mill represents a much-needed resource for neighboring mining projects who have already expressed an interest in custom milling agreements
- LaFleur expects to have the mill restarted in early 2026 following completion of a few basic upgrades
- LaFleur also anticipates using the mill operation for its own production as anticipated mining for mineralized material gets under way at the company’s Swanson Gold Project

The assets held by gold exploration and development company LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) amount to a way for investors to get into the gold market even if they aren’t eager to buy into precious metals commodities during the current record price trend.

LaFleur is exploring the potential of the approximately 18,304 hectares (45,230 acres) at its Swanson Gold Project in Quebec, strategically situated on Canada’s Abitibi Greenstone Belt, but the company also anticipates that its 100%-owned Beacon Gold Mill will drive near-term revenues simply by being available to process mineralized material from other nearby mines and deposits in the region at a time when the rising market has been reporting repeated new record pricing (https://nnw.fm/xnRfo ).

J.P. Morgan Research analysts have forecast a potential continuation of the market trend, anticipating gold prices over $4,000 per ounce by next year (https://nnw.fm/WQMVc ). Other analysts question if gold’s rapid rise indicates it is approaching the point of forming a bubble (https://nnw.fm/ATAG5 ). Either way, LaFleur’s strategic approach to building capital shows a readiness to make the most of the market.

The Beacon Gold Mill is capable of processing over 750 metric tons of raw ore per day. The mill had received more than $20 million in equipment and other upgrades by a former owner and is preparing for an estimated $3-5 million in restart upgrades that will improve its tailings pond and facility.

“We recently had an engineering group go in and do a full valuation on it … and they concluded it was in excellent condition,” LaFleur CEO Paul Ténière said during a Crux Investor interview last month (https://nnw.fm/L2kR5 ).

“We anticipate roughly four to six months to get the full ramp-up completed and back into production. So we’re aiming for sort of early 2026 to be back in full production,” he added. “We’ve had lots of companies ask us about it, and it’s sort of the, you know, get it going and they will come. They want to see the mill back up and running — they say, ‘Hey, … we’d be interested in potentially doing agreements with you for processing box samples or even custom milling.”

While the near-term revenue strategy is expected to get the company up and rolling, LaFleur is still building toward mining its own mineralized material and processing it through the Beacon plant. With a greater measure of control over its own processes, low restart cost to production and with a fully integrated model of resource to production, the company can maximize its appeal to investors.

The company began drilling at its site this summer, and core logging shows the consistent presence of pyrite and other sulfides that are classic pathfinder minerals for gold, with initial assays from the 5,000 metre drilling program at Swanson to be announced near-term.

“We’re particularly optimistic about the mineralized zone encountered in hole SW-025-038 (a sulphide-rich zone known to be at least 17.9 meters wide) and we look forward to releasing assay results in the near future,” Ténière stated in an Aug. 7 news release (https://nnw.fm/Sublz ).

LaFleur has filed an updated NI 43-101 Technical Report for the project dated July 29.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://nnw.fm/LFLRF

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

LaFleur Minerals Inc. (LFLRF) Stock Research Links

LFLRF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Device Transforms Golf Ball Pickup Experience

Updated Category News Views 451

Revolutionary Device Enhances Golf Ball Retrieval Inventors are always looking for ways to simplify tasks and improve our experiences. One innovative creator has unveiled a practical solution for golfers: the BALL PICK. This device addresses a common struggle faced by golfers at all skill levels – the hassle of bending down to pick up golf balls. Imagine a device that...

Continue Reading
HCSC Introduces Simplified Health Care Coverage Alternative

Updated Category News Views 321

HCSC Launches a New Streamlined Health Care Coverage Option Health Care Service Corporation (HCSC) is thrilled to announce a new health plan designed to simplify the healthcare experience for its members. This innovative option is aimed at individuals looking for a more straightforward way to handle their healthcare expenses. Simplified Monthly Billing with No Deductibles...

Continue Reading
Desvelados Mexican Cantina: A Flavorful New Gem in Town

Updated Category News Views 314

Desvelados Mexican Cantina Is Now Open In a vibrant celebration, Desvelados Mexican Cantina has opened its doors, bringing authentic Mexican flavors to the local dining scene. This lively cantina invites food lovers to indulge in an array of mouthwatering dishes, making it the perfect spot for gatherings with friends and family. Dining Experience at Desvelados Upon...

Continue Reading
Promising Results from Arcus Biosciences’ Casdatifan in Cancer Trials

Updated Category News Views 67

Groundbreaking Developments in Cancer Treatment Arcus Biosciences, Inc. (NYSE:RCUS), a leader in biopharmaceutical innovation, has recently presented compelling clinical data regarding their leading candidate, casdatifan, a HIF-2a inhibitor that shows outstanding promise in treating metastatic kidney cancer. The data was shared by Dr. Toni K. Choueiri at a significant...

Continue Reading
Understanding Options Movement in Johnson & Johnson Stock

Updated Category News Views 203

Key Insights on Johnson & Johnson Options Activity Investors are paying close attention to the options market for Johnson & Johnson (NYSE: JNJ), as recent activities indicate a bearish stance among high-profile investors. Understanding these movements can be valuable for retail traders looking to navigate the complexities of stock trading. Recent Options Trends Recently,...

Continue Reading